What is the address of Dr. H. Audiens - Pediater?

The registered office of Dr. H. Audiens - Pediater is located at Stuivenbergvaart 114, 2800 Mechelen.

Is Dr. H. Audiens - Pediater still active?

Yes. According to the CBE (29 September 2026) Dr. H. Audiens - Pediater is active, legal situation “Normale toestand”, started on 9 January 2017.

Is Dr. H. Audiens - Pediater registered on Peppol?

Yes, Dr. H. Audiens - Pediater is registered on the Peppol network with ID 0208:0668859738.

What is the enterprise number of Dr. H. Audiens - Pediater?

The enterprise number of Dr. H. Audiens - Pediater is BE0668859738.

When was Dr. H. Audiens - Pediater founded?

Dr. H. Audiens - Pediater was founded on 9 January 2017.

Who are the directors of Dr. H. Audiens - Pediater?

According to the 2025 annual accounts, the directors of Dr. H. Audiens - Pediater are: Hilde Audiens.

Is Dr. H. Audiens - Pediater a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 9 January 2017; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did Dr. H. Audiens - Pediater make in 2025?

Dr. H. Audiens - Pediater posted a profit after taxes of € 163,523 in financial year 2025.

What is the revenue of Dr. H. Audiens - Pediater?

As a small company, Dr. H. Audiens - Pediater is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 274,377.

Dr. H. Audiens - Pediater (Private Limited) - Mechelen

Dossier Dr. H. Audiens - Pediater, printed on 29 September 2026 from databakkes.be/en/0668859738/dr-h-audiens-pediater. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

Dr. H. Audiens - Pediater from Mechelen, company number BE0668859738, closed financial year 2025 with a result of € 163,523 after tax. For that financial year Dr. H. Audiens - Pediater recorded a gross margin of € 274,377 and equity of € 357,940. Compared with financial year 2024, the result moved from € 157,539 to € 163,523. Profitable, and profit is growing. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on April 13, 2026.

What it is worth Healthy

€ 357,940

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 163,523

▲ 4% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 33,008

▲ 162% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 164,000 paid out

100 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Vehicles and equipment

€ 22,470

▲ 157% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

€ 7,957

▼ 88% vs 2024

Loans from banks and other lenders, long and short.

Owed to suppliers

€ 2,025

▼ 44% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 5,963

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 319,714 Gross margin 2022: € 319,714 First fiscal year in the series	€ 309,949 Gross margin 2023: € 309,949 ▼ 3% vs 2022 (€ 319,714) Unfavourable step	€ 274,403 Gross margin 2024: € 274,403 ▼ 11% vs 2023 (€ 309,949) Unfavourable step	€ 274,377 Gross margin 2025: € 274,377 Unchanged (€ 274,403) Unfavourable step
Profit after taxes	€ 202,562 Profit after taxes 2022: € 202,562 First fiscal year in the series	€ 179,673 Profit after taxes 2023: € 179,673 ▼ 11% vs 2022 (€ 202,562) Unfavourable step	€ 157,539 Profit after taxes 2024: € 157,539 ▼ 12% vs 2023 (€ 179,673) Unfavourable step	€ 163,523 Profit after taxes 2025: € 163,523 ▲ 4% vs 2024 (€ 157,539) Favourable step	▲ 4%
Equity	€ 309,204 Equity 2022: € 309,204 First fiscal year in the series	€ 200,877 Equity 2023: € 200,877 ▼ 35% vs 2022 (€ 309,204) Unfavourable step	€ 358,416 Equity 2024: € 358,416 ▲ 78% vs 2023 (€ 200,877) Favourable step	€ 357,940 Equity 2025: € 357,940 Unchanged (€ 358,416) Unfavourable step
Total debts	€ 293,689 Total debts 2022: € 293,689 First fiscal year in the series	€ 425,698 Total debts 2023: € 425,698 ▲ 45% vs 2022 (€ 293,689) Unfavourable step	€ 77,485 Total debts 2024: € 77,485 ▼ 82% vs 2023 (€ 425,698) Favourable step	€ 179,945 Total debts 2025: € 179,945 ▲ 132% vs 2024 (€ 77,485) Unfavourable step	▲ 132%
Cash	€ 125,626 Cash 2022: € 125,626 First fiscal year in the series	€ 38,210 Cash 2023: € 38,210 ▼ 70% vs 2022 (€ 125,626) Unfavourable step	€ 12,617 Cash 2024: € 12,617 ▼ 67% vs 2023 (€ 38,210) Unfavourable step	€ 33,008 Cash 2025: € 33,008 ▲ 162% vs 2024 (€ 12,617) Favourable step	▲ 162%
Land & buildings	-	-	-	€ 32,577 Land & buildings 2025: € 32,577 First fiscal year in the series
Retained profit	€ 290,604 Retained profit 2022: € 290,604 First fiscal year in the series	€ 182,277 Retained profit 2023: € 182,277 ▼ 37% vs 2022 (€ 290,604) Unfavourable step	€ 339,816 Retained profit 2024: € 339,816 ▲ 86% vs 2023 (€ 182,277) Favourable step	€ 339,340 Retained profit 2025: € 339,340 Unchanged (€ 339,816) Unfavourable step
Dividend	€ 117,647 Dividend 2022: € 117,647 First fiscal year in the series	€ 288,000 Dividend 2023: € 288,000 ▲ 145% vs 2022 (€ 117,647) Unchanged	€ 0 Dividend 2024: € 0 ▼ 100% vs 2023 (€ 288,000) Unchanged	€ 164,000 Dividend 2025: € 164,000 Unchanged (€ 0) Unchanged
Bank debt	€ 167,256 Bank debt 2022: € 167,256 First fiscal year in the series	€ 96,702 Bank debt 2023: € 96,702 ▼ 42% vs 2022 (€ 167,256) Favourable step	€ 67,902 Bank debt 2024: € 67,902 ▼ 30% vs 2023 (€ 96,702) Favourable step	€ 7,957 Bank debt 2025: € 7,957 ▼ 88% vs 2024 (€ 67,902) Favourable step	▼ 88%
Balance sheet total	€ 602,893 Balance sheet total 2022: € 602,893 First fiscal year in the series	€ 626,575 Balance sheet total 2023: € 626,575 ▲ 4% vs 2022 (€ 602,893) Unchanged	€ 435,901 Balance sheet total 2024: € 435,901 ▼ 30% vs 2023 (€ 626,575) Unchanged	€ 537,884 Balance sheet total 2025: € 537,884 ▲ 23% vs 2024 (€ 435,901) Unchanged	▲ 23%

Key figures of Dr. H. Audiens - Pediater, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Dr. H. Audiens - Pediater?

What happened at Dr. H. Audiens - Pediater in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Apr 13, 2026 New annual accounts for financial year 2025: profit of € 163,523 (▲ 4% vs 2024). Source: NBB ↗
Jan 9, 2017 New establishment in Mechelen. KBO
Jan 9, 2017 Start of the company according to the CBE. KBO
2017 Hilde Audiens became a director. NBB

In short

From € 202,562 profit in 2022 to € 163,523 profit in 2025.

Paid € 257,403 in corporate taxes since 2022.

Best year ever: 2022, with € 202,562 profit.

Paid out € 569,647 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at Dr. H. Audiens - Pediater? We notify you, reason included.

Follow Dr. H. Audiens - Pediater

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Hilde Audiens

Dr. H. Audiens - Pediater

H. Audiens

Behind Dr. H. Audiens - Pediater is Hilde Audiens. Hilde Audiens is also behind H. Audiens.

See the full network in the app

Directors

According to the 2025 annual accounts

Hilde Audiens

Director

Also active at: H. Audiens

since 2017

Establishments

Establishment units

Physical locations of this company

Registered office

Stuivenbergvaart 114

2800 Mechelen

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0668.859.738
VAT number: BE 0668.859.738
Registered office: Stuivenbergvaart 114, 2800 Mechelen
Names & denominations: Dr. H. Audiens - Pediater
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 9 January 2017
Peppol: Active · Active since 1 Jan 2001

View on CBE Public ↗ Annual accounts (NBB) ↗